C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 275/32 (2006.01) A61K 31/165 (2006.01) A61K 31/255 (2006.01) A61K 31/506 (2006.01) A61P 11/06 (2006.01) C07C 233/41 (2006.01) C07C 233/79 (2006.01) C07C 275/34 (2006.01) C07C 317/44 (2006.01) C07C 317/48 (2006.01) C07D 239/04 (2006.01) C07D 239/38 (2006.01)
Patent
CA 2459364
The present invention relates to 1,2-diaminocyclopentane derivatives of Formula (I), wherein R1 - R4 are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for the treatment of CCR-3 mediated diseases.
L'invention concerne des dérivés de 1,2-diaminocyclopentane de formule (I), dans laquelle R¿1?-?R¿4? sont tels que définis dans la description. Les composés sont utiles comme antagonistes du récepteur CCR-3 et peuvent, par conséquent, être utilisés pour le traitement de maladies induites par CCR-3.
Borden Ladner Gervais Llp
F. Hoffmann-La Roche Ag
LandOfFree
Ccr-3 receptor antagonists v does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ccr-3 receptor antagonists v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ccr-3 receptor antagonists v will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2012070